Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Non-Current Debt (2011 - 2026)

Skinvisible's (SKVI) quarterly Non-Current Debt came in at $5.4 million in Q2 2026, little changed year-over-year from $5.4 million in Q2 2025, and little changed quarter-over-quarter from $5.4 million in Q1 2026.

Analysis

Skinvisible (SKVI) Non-Current Debt (2011 - 2026) Analysis & Trends

Skinvisible has disclosed Non-Current Debt across 16 years of filings, most recently posting $5.4 million for Q2 2026.

  • In Q2 2026, Non-Current Debt changed 0.0% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (changed 0.0% YoY), while the FY2025 annual figure was $5.4 million, changed 0.0% from the prior year.
  • Non-Current Debt came in at $5.4 million for Q2 2026 at Skinvisible, roughly flat from $5.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $5.4 million in Q2 2023 to a low of $433600.0 in Q1 2022.
  • Average Non-Current Debt over 5 years is $4.4 million, with a median of $5.4 million recorded in 2023.
  • Year-over-year, Non-Current Debt dropped 21.45% in 2022 and soared 1139.02% in 2023.
  • Over 5 years, Non-Current Debt stood at $3.0 million in 2022, then soared by 79.55% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025, then changed by 0.0% to $5.4 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $5.4 million in Q2 2026, $5.4 million in Q1 2026, and $5.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 647.06 Bn 626.30 Bn 17.26 Bn 37.34 Bn
2 AbbVie 440.06 Bn 433.49 Bn 12.70 Bn 62.48 Bn
3 Merck 364.19 Bn 357.05 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 268.45 Bn 260.76 Bn 11.24 Bn -
5 Pfizer 158.40 Bn 146.70 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.57 Bn 45.19 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 44.32 Bn 44.32 Bn - -
8 Incyte 24.98 Bn 20.44 Bn 1.57 Bn -
9 United Therapeutics 21.15 Bn 18.49 Bn 683.80 Mn -
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 5.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.37 Mn
Mar 31, 2026 5.37 Mn
Dec 31, 2025 5.37 Mn
Sep 30, 2025 5.37 Mn
Jun 30, 2025 5.37 Mn
Mar 31, 2025 5.37 Mn
Dec 31, 2024 5.37 Mn
Sep 30, 2024 5.37 Mn
Jun 30, 2024 5.37 Mn
Mar 31, 2024 5.37 Mn
Dec 31, 2023 5.37 Mn
Sep 30, 2023 5.37 Mn
Jun 30, 2023 5.37 Mn
Mar 31, 2023 5.37 Mn
Dec 31, 2022 2.99 Mn
Sep 30, 2022 433,600.00
Jun 30, 2022 433,600.00
Mar 31, 2022 433,600.00
Dec 31, 2021 433,600.00
Sep 30, 2021 445,600.00